Rou-Shayn Chen

Open AccessArticle by Po-Chun Chu 1, Chen-Syuan Huang 1, Pi-Kai Chang 2, Rou-Shayn Chen 3, Ko-Ting Chen 4,5, Tsung-Hsun Hsieh 5,6,7,* and Hao-Li Liu 1,* 1 Department of Electrical Engineering, National Taiwan University, Taipei 10617, Taiwan 2 Department of Pediatrics, School of Medicine, University of Utah, Salt Lake City, UT 84112, USA 3 Division of Movement Disorder, Department of Neurology, Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Taipei 10507, Taiwan 4...

[Skip to Content Landing] Figure 1. Flowchart of the Study Cohorts HCV indicates hepatitis C virus. Figure 2. Event Rate of Parkinson Disease (PD) in Each Study Cohort The difference in the development of Parkinson disease in the treated and untreated cohorts enlarged gradually with time and reached statistical significance since year 5 (hazard ratio [HR], 0.75; 95% CI, 0.59-0.96) to the end of the cohort (HR, 0.71; 95% CI, 0.58-0.87). Figure 3.